Metrion has launched the NaV1.9 screening assay, aimed at progressing the discovery along with the development of new pain ...

The letter acknowledged the potential of brain-computer interface technology yet noted that neurotech collects brain data ...

The US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device.

Gestalt Diagnostics has completed a Series A financing round, raising $7.5m for expanding its AI-powered PathFlow pathology ...

J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial.